Detalhe da pesquisa
1.
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy.
Hematol Oncol
; 38(4): 501-508, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32602970